REDX.L Share News (REDX)

REDX.L Information

There is currently no data for REDX

DIRECTOR DEALINGS: Redx Pharma Chairman, Non-Executives Buy Shares

Fri, 06th Nov 2015 09:42

LONDON (Alliance News) - Drug discovery and development company Redx Pharma PLC on Friday said its chairman and two non-executive directors bought shares in the company on Thursday.

Chairman Frank Armstrong bought 6,250 shares while non-executive directors Norman Molyneux and Peter Jackson bought 6,250 and 5,625 shares each, respectively.

Armstrong now owns a 0.03% stake in the company, while Molyneux owns 0.4% and Jackson owns 5.0%.

Shares in Redx were up 0.9% to 80.75p on Friday.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

More News

11 Mar 2020 10:23

Redx Pharma Optimistic As Loss Narrows And Cancer Trial Progresses

28 Feb 2020 18:47

UPDATE: Redx Pharma To Get GBP26 Million Injection Amid No Yesod Bid

28 Feb 2020 18:08

No Redx Pharma Takeover As Yesod Opts Not To Make Offer

14 Feb 2020 17:11

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

28 Jan 2020 14:15

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

24 Jan 2020 11:51

Moulton Goodies Raises Stake In Redx Pharma To 42% From 18%

9 Jan 2020 16:02

Redx Pharma nominates next drug development candidate

(Sharecast News) - Drug discovery and development company Redx Pharma announced the nomination of RXC007 as its next drug development candidate for the treatment of fibrosis on Thursday.

9 Jan 2020 11:17

Redx Pharma Nominates Another Anti-Fibrosis Drug Candidate

31 Dec 2019 10:34

UK WINNERS & LOSERS SUMMARY: Redx Surges On Potential Takeover Offer

31 Dec 2019 09:12

Redx Pharma Shares Soar On Discussions Over Possible Takeover Offer

31 Dec 2019 08:51

LONDON MARKET OPEN: Stocks Start Mostly Lower Amid Profit Taking

19 Nov 2019 12:29

Redx collaboration with MDC awarded Innovate UK funding

(Sharecast News) - Redx Pharma announced on Tuesday that Innovate UK has awarded biomedical catalyst funding to Redx and Medicines Discovery Catapult (MCD).

19 Nov 2019 11:53

Redx Pharma Secures Funding To Develop Lung Condition Therapies

19 Aug 2019 10:22

Redx Pharma Gets Approval To Escalate Dose In RXC004 Study

(Alliance News) - Redx Pharma PLC on Monday said it has successfully completed dosing of the first cohort of patients in its ongoing phase 1/2 study with RXC004.RXC004 is an oral porcupine

19 Aug 2019 09:43

Redx Pharma gets green light to escalate dose in RXC004 study

(Sharecast News) - Drug discovery and development company Redx Pharma has successfully completed dosing of the first cohort of patients in its ongoing phase 1 and 2 study with 'RXC004', it announced on Monday.

Latest Share Chat

REDX.L Share News (REDX)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Redx Pharma Chairman, Non-Executives Buy Shares

Login to your account

Quickpicks are a member only feature

Login to your account